...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Applied Microbiology >Public Health Risks of Multiple-Drug-Resistant Enterococcus spp. in Southeast Asia
【24h】

Public Health Risks of Multiple-Drug-Resistant Enterococcus spp. in Southeast Asia

机译：多药耐药肠球菌的公共健康风险。在东南亚

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Enterococci rank as one of the leading causes of nosocomial infections, such as urinary tract infections, surgical wound infections, and endocarditis, in humans. These infections can be hard to treat because of the rising incidence of antibiotic resistance. Enterococci inhabiting nonhuman reservoirs appear to play a critical role in the acquisition and dissemination of antibiotic resistance determinants. The spread of antibiotic resistance has become a major concern in both human and veterinary medicine, especially in Southeast Asia, where many developing countries have poor legislation and regulations to control the supply and excessive use of antimicrobials. This review addresses the occurrence of antibiotic-resistant enterococci in Association of Southeast Asian Nations countries and proposes infection control measures that should be applied to limit the spread of multiple-drug-resistant enterococci.
机译：肠球菌是人类医院感染（例如尿路感染，手术伤口感染和心内膜炎）的主要原因之一。由于抗生素耐药性的发生率不断上升，这些感染可能难以治疗。居住在非人类宿主中的肠球菌似乎在获取和传播抗生素抗性决定簇中起关键作用。抗生素耐药性的传播已成为人类和兽药的主要关注点，尤其是在东南亚，在东南亚，许多发展中国家的立法和法规缺乏控制抗生素的供应和过度使用的法规。这项审查解决了东南亚国家联盟中抗生素耐药性肠球菌的发生，并提出了应采取的感染控制措施，以限制多重耐药性肠球菌的传播。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号